Carl Zeiss Meditec AG
XETRA:AFX

Watchlist Manager
Carl Zeiss Meditec AG Logo
Carl Zeiss Meditec AG
XETRA:AFX
Watchlist
Price: 46.62 EUR 0.52% Market Closed
Market Cap: 4.2B EUR
Have any thoughts about
Carl Zeiss Meditec AG?
Write Note
AFX
/
Balance Sheet
/
Long-Term Debt

Carl Zeiss Meditec AG
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Carl Zeiss Meditec AG
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Carl Zeiss Meditec AG
XETRA:AFX
Long-Term Debt
€217m
CAGR 3-Years
4%
CAGR 5-Years
6%
CAGR 10-Years
34%
Stratec SE
XETRA:SBS
Long-Term Debt
€93.6m
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
33%
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
Long-Term Debt
€42.7m
CAGR 3-Years
32%
CAGR 5-Years
23%
CAGR 10-Years
12%
Siemens Healthineers AG
XETRA:SHL
Long-Term Debt
€14.4B
CAGR 3-Years
5%
CAGR 5-Years
226%
CAGR 10-Years
N/A
Draegerwerk AG & Co KGaA
XETRA:DRW8
Long-Term Debt
€254.5m
CAGR 3-Years
10%
CAGR 5-Years
16%
CAGR 10-Years
4%
Sartorius AG
XETRA:SRT
Long-Term Debt
€4.4B
CAGR 3-Years
36%
CAGR 5-Years
37%
CAGR 10-Years
26%
No Stocks Found

Carl Zeiss Meditec AG
Glance View

Market Cap
4.2B EUR
Industry
Health Care
Economic Moat
None

Carl Zeiss Meditec AG stands as a beacon in the realm of medical technology, carving a niche through its innovative solutions in ophthalmology and microsurgery. Rooted in the prestigious legacy of the Zeiss Group, this company seamlessly fuses cutting-edge technology with practical medical applications. Its headquarters in Jena, Germany, serve as the crucible for pioneering research and development endeavors, channeling expertise into products that enhance both diagnostic and surgical capabilities. The heart of its operations revolves around creating technological marvels such as optical coherence tomography (OCT) instruments and surgical microscopes, which bring precision and enhanced clarity to the medical field. Through a well-executed blend of R&D and strategic acquisitions, Carl Zeiss Meditec consistently remains at the forefront of medical innovation, ensuring it meets the ever-evolving needs of the healthcare sector. Financially, the company thrives by selling its sophisticated medical devices directly to healthcare professionals, hospitals, and clinics worldwide. Rather than merely creating instruments, Carl Zeiss Meditec's business model is deeply entwined with providing comprehensive workflow solutions and service support, ensuring that medical practitioners extract maximum utility from their investments. By offering not just products but also extensive after-sales service and maintenance, the company builds sustained relationships with its clients, fostering a cycle of trust and repeat business. In addition, its engagement in training and support services enhances user competencies, ensuring the seamless integration of its technology into everyday medical practice and underscoring its commitment to elevating healthcare standards globally. Through this multifaceted approach, Carl Zeiss Meditec solidifies its position as an indispensable ally in the medical community, both as a supplier of state-of-the-art equipment and as a provider of essential healthcare solutions.

AFX Intrinsic Value
91.75 EUR
Undervaluation 49%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Carl Zeiss Meditec AG's Long-Term Debt?
Long-Term Debt
217m EUR

Based on the financial report for Jun 30, 2024, Carl Zeiss Meditec AG's Long-Term Debt amounts to 217m EUR.

What is Carl Zeiss Meditec AG's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
34%

Over the last year, the Long-Term Debt growth was 9%. The average annual Long-Term Debt growth rates for Carl Zeiss Meditec AG have been 4% over the past three years , 6% over the past five years , and 34% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 211,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.